Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Plumbago zeylanica has valuable medicinal properties but needs sustainable cultivation methods.

Higher sebum levels are linked to more severe male baldness.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Genetic mutations can affect female sexual development, requiring personalized medical care.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Mutations in the ST14 gene cause skin and hair issues by disrupting important protein processing.